Abstract
Bacteria commonly communicate with each other by a cell-to-cell signaling mechanism known as quorum sensing, using soluble mediators. Recent studies showed that these molecules target not only bacteria, but also interact with the eukaryotic host. Pseudomonas aeruginosa infection occurs both in acute or chronic states in a variety of respiratory and urinary infections. These infections are often difficult to treat, and numerous therapeutic options, besides antibiotics, have been searched. In this context quorum-sensing inhibitors could represent an attractive potential therapeutic strategy with promising results.
Keywords: Autoinducers, Host-pathogen relationship, Immunomodulation, Inter-kingdom communication, Pseudomonas aeruginosa, Quorum sensing
Current Organic Chemistry
Title:Pseudomonas aeruginosa -Eukaryotic Cell Crosstalk: Mediators, Mechanisms and Implications for the Antimicrobial Therapy
Volume: 17 Issue: 2
Author(s): Carmen Curutiu, Mariana Carmen Chifiriuc and Magda Mihaela Mitache
Affiliation:
Keywords: Autoinducers, Host-pathogen relationship, Immunomodulation, Inter-kingdom communication, Pseudomonas aeruginosa, Quorum sensing
Abstract: Bacteria commonly communicate with each other by a cell-to-cell signaling mechanism known as quorum sensing, using soluble mediators. Recent studies showed that these molecules target not only bacteria, but also interact with the eukaryotic host. Pseudomonas aeruginosa infection occurs both in acute or chronic states in a variety of respiratory and urinary infections. These infections are often difficult to treat, and numerous therapeutic options, besides antibiotics, have been searched. In this context quorum-sensing inhibitors could represent an attractive potential therapeutic strategy with promising results.
Export Options
About this article
Cite this article as:
Curutiu Carmen, Carmen Chifiriuc Mariana and Mihaela Mitache Magda, Pseudomonas aeruginosa -Eukaryotic Cell Crosstalk: Mediators, Mechanisms and Implications for the Antimicrobial Therapy, Current Organic Chemistry 2013; 17 (2) . https://dx.doi.org/10.2174/1385272811317020011
DOI https://dx.doi.org/10.2174/1385272811317020011 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Teratological Consequences of Nitric Oxide Synthesis Inhibition
Current Pharmaceutical Design Why Does Obesity Increase the Risk for Cardiovascular Disease?
Current Pharmaceutical Design Controlled and Continuous Release Ocular Drug Delivery Systems: Pros and Cons
Current Drug Delivery Role of Nitrosative Stress and Poly(ADP-ribose) Polymerase Activation in Diabetic Vascular Dysfunction
Current Vascular Pharmacology Gold Nanoparticles - Synthesis and Applications in Cancer Management
Recent Patents on Materials Science The Role of microRNAs in the Initiation and Progression of Stable Atheromatous Plaque
Current Pharmaceutical Design Docking, Synthesis and Anti-Diabetic Activity of Novel Sulfonylhydrazone Derivatives Designed as PPAR-Gamma Agonists
Current Topics in Medicinal Chemistry Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy
Current Medicinal Chemistry A Prospective Study of the Clinical and Demographic Profile of Type 2 Diabetes Mellitus Patients Receiving Antidiabetic Drug Combinations
Current Diabetes Reviews Metformin in the Treatment of Polycystic Ovary Syndrome
Current Pharmaceutical Design Diabetes, the Renin-Angiotensin System and Heart Disease
Current Vascular Pharmacology Protective Effect of Aspirin Against Oligomeric Aβ42 Induced Mitochondrial Alterations and Neurotoxicity in Differentiated EC P19 Neuronal Cells
Current Alzheimer Research HIV-1 Vectors: Fulfillment of Expectations, Further Advancements, and Still A Way To Go
Current HIV Research The Inhibitory Effect of Panax Ginseng Extract on Amyloid-like Fibril Formation of Trypsin in Aqueous Ethanol
Protein & Peptide Letters Editorial (Thematic Issue: “Pregnancy in Women with Metabolic Syndrome”)
Current Pharmaceutical Biotechnology Direct Renin Inhibition: Promising Treatment in Renoprotection?
Recent Patents on Cardiovascular Drug Discovery Physiological Significance of Resistin and Resistin-Like Molecules in the Inflammatory Process and Insulin Resistance
Current Diabetes Reviews Delivery systems for biopharmaceuticals. Part II: Liposomes, Micelles, Microemulsions and Dendrimers
Current Pharmaceutical Biotechnology Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Current Pharmaceutical Design Epigenetic Modulation: A Promising Avenue to Advance Hematopoietic Stem Cell-Based Therapy for Severe Autoimmune Disorders
Epigenetic Diagnosis & Therapy (Discontinued)